MoonLake Immunotherapeutics Class A (MLTX) is currently at $48.03, up $6.87 or 16.69%
--Would be highest close since Jan. 8, 2025, when it closed at $48.17
--On pace for largest percent increase since June 26, 2023, when it rose 77.55%
--Currently up four consecutive days; up 25.83% over this period
--Longest winning streak since April 21, 2025, when it rose for six straight trading days
--Best four-day stretch since the four days ending June 29, 2023, when it rose 97.37%
--Down 11.3% year-to-date
--Down 24.79% from its all-time closing high of $63.86 on Feb. 12, 2024
--Up 17.69% from 52 weeks ago (June 4, 2024), when it closed at $40.81
--Down 14.69% from its 52-week closing high of $56.30 on Dec. 17, 2024
--Up 46.28% from its 52-week closing low of $32.84 on April 8, 2025
--Traded as high as $49.29; highest intraday level since Jan. 8, 2025, when it hit $50.50
--Up 19.75% at today's intraday high; largest intraday percent increase since June 26, 2023, when it rose as much as 102.18%
All data as of 10:46:39 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 03, 2025 10:54 ET (14:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.